Director Office of CV Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States
Dr. Bram Zuckerman is a graduate of the Boston University Medical School. He completed post-graduate training in internal medicine at Baltimore City Hospital and cardiology at the Johns Hopkins program. Prior to joining FDA in 1992, he was involved in basic research in hemodynamics at the University of Colorado Medical School and practiced noninvasive and invasive cardiology in Denver, Colorado and Northern Virginia. He joined the FDA Division of Cardiovascular Devices (DCD) as a Medical Officer in 1992 and has been actively involved in development and review of clinical trials for many new cardiovascular devices. In May 2001 he was appointed a Deputy Director in DCD. He was appointed as Director of the FDA Division of Cardiovascular Devices in September 2002 and in May 2019 became Director of the FDA Office of Cardiovascular Devices.
No relationships to disclose
Discussion: What Directions and Working Groups Best Fit Shock Evidence Priorities for 2024?
Friday, March 8, 2024
5:45 PM – 6:30 PM ET
Saturday, March 9, 2024
1:00 PM – 1:05 PM ET
SESSION V: REPORTS FROM BREAKOUT SESSIONS
Saturday, March 9, 2024
6:00 PM – 7:00 PM ET
Overview Discussion, Comments & Next Steps
Saturday, March 9, 2024
6:40 PM – 7:00 PM ET
Sunday, March 10, 2024
12:50 PM – 1:00 PM ET
Panel Discussion | The Future of Cardiovascular Innovation - Impact on Clinical Practice
Sunday, March 10, 2024
1:25 PM – 1:45 PM ET
FDA Valve and Structural Innovations Town Hall [Non-CME]
Monday, March 11, 2024
2:00 PM – 6:00 PM ET
Tuesday, March 12, 2024
8:00 AM – 12:30 PM ET
Keynote Lecture: FDA's Office of Cardiovascular Devices: Current Status and Priorities
Tuesday, March 12, 2024
8:40 AM – 8:55 AM ET
Tuesday, March 12, 2024
9:30 AM – 10:30 AM ET
Panel Discussion: Leveraging Real-World Evidence: Where Are We Now and What Lies Ahead?
Tuesday, March 12, 2024
10:02 AM – 10:30 AM ET